How Semaglutide works Slows how quickly food leaves the stomach, which helps you feel full for longer Decreases appetite and reduces cravings, making it easier to avoid mindless snacking Improves insulin sensitivity, which supports steadier energy and better metabolic control FDA approvals Semaglutide was first approved to treat type 2 diabetes
CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office
A significant wave of patent and data protection expires in 2026 across eight key markets in wave 1: Canada, Brazil, China, India, Mexico , Turkey, Saudi Arabia* and South Africa (see Figure 1)
Constraint-based modeling of bioenergetic differences between synaptic and non-synaptic components of dopaminergic neurons in Parkinson's disease